StockNews.com Begins Coverage on Alimera Sciences (NASDAQ:ALIM)
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note released on Tuesday. The firm issued a buy rating on the biopharmaceutical company’s stock. Several other brokerages have also commented on ALIM. Alliance Global Partners raised Alimera Sciences from a neutral rating to a buy rating in a report […]